[1] Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282(5391): 1145-1147.[2] Wakayama T, Tabar V, Rodriguez I, et al. Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science. 2001; 292(5517): 740-743.[3] Wilmut I, Schnieke AE, McWhir J, et al. Viable offspring derived from fetal and adult mammalian cells. Nature. 1997; 385 (6619):810-813.[4] Cowan CA, Atienza J, Melton DA, et al. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science. 2005; 309(5739): 1369-1373.[5] Nichols J, Zevnik B, Anastassiadis K, et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell. 1998; 95(3): 379-391.[6] Avilion AA, Nicolis SK, Pevny LH, et al. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 2003; 17(1): 126-140.[7] Chambers I, Colby D, Robertson M, et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell. 2003;113(5):643-655.[8] Matsuda T, Nakamura T, Nakao K, et al. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J. 1999;18(15):4261-4269.[9] Cartwright P, McLean C, Sheppard A, et al. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development. 2005; 132(5): 885-896.[10] Li Y, McClintick J, Zhong L, et al. Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. Blood. 2005; 105(2): 635-637.[11] Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4): 663-676. [12] 潘光锦,裴端卿.维持胚胎干细胞多能性的分子机制[J].生命科学, 2007,19(4): 372-377.[13] Doege CA, Inoue K, Yamashita T, et al. Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2. Nature. 2012;488(7413):652- 655.[14] Wang T, Chen K, Zeng X, et al. The Histone Demethylases Jhdm1a/1b Enhance Somatic Cell Reprogramming in an Vitamin-C-Dependent Manner. Cell Stem Cell. 2011;9(6): 575-587.[15] Ben-David U, Mayshar Y, Benvenisty N. Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. Cell Stem Cell. 2011; 9(2): 97-102 .[16] Hussein SM, Batada NN, Vuoristo S, et al. Copy number variation and selection during reprogramming to pluripotency. Nature. 2011; 471(7336): 58-62. [17] Nakano T. Lymphohematopoietic development from embryonic stem cells in vitro. Semin Immunol. 1995; 7(3): 197-203.[18] Cho SK, Webber TD, Carlyle JR, et al. Functional characterization of B lymphocytes generated in vitro from embryonic stem cells. Proc Natl Acad Sci USA.1999; 96(17): 9797-9802.[19] Wada H, Kojo S, Kusama C, et al. Successful differentiation to T cells, but unsuccessful B-cell generation, from B-cell-derived induced pluripotent stem cells. Int Immunol. 2011; 23(1): 65-74.[20] Aasen T, Raya A, Barrero MJ, et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol. 2008; 26(11):1276-1284.[21] Cai J, ESteban MA, Pei D, et al. Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells. J Biol Chem. 2010; 285(15): 11227-11234.[22] Hanna J, Markoulaki S, Schorderet P, et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell. 2008; 133(2): 250-264.[23] Hu K, Yu J, Suknuntha K, et al. Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood. 2011; 117(14):e109-119.[24] Giorgetti A, Montserrat N, Aasen T, et al. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell. 2009;5(4): 353-357.[25] Haase A, Olmer R, Schwanke K,et al. Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell. 2009; 5(4): 434-441.[26] Raymond M, Anchan, Philipp Quaas, et al. Amniocytes can serve a dual function as a source of iPS cells and feeder layers. Hum Mol Genet. 2011; 20(5): 962-974.[27] Stadtfeld M, Brennand K, Hochedlinger K. Reprogramming of pancreatic beta cells into induced pluripotentstem cells. Current Biology. 2008; 18(12): 890-894.[28] Kim JB, Zaehres H, Wu G, et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature. 2008; 454(7204): 646-650.[29] Tan KY, Eminli S, Hettmer S, et al. Efficient generation of iPS cells from skeletal muscle stem cells. PLoS One. 2011; 6(10):e26406. [30] Zhou T, Pei D, Esteban MA, et al. Generation of Induced Pluripotent Stem Cells from Urine. J Am Soc Nephrol. 2011; 22(7):1221-1228.[31] Niibe K, Kawamura Y, Araki D, et al. Purified mesenchymal stem cells are an efficient source for iPS cell induction. PLoS One. 2011;6(3):e17610.[32] Kim K, Doi A, Wen B, et al. Epigenetic memory in induced pluripotent stem cells. Nature. 2010; 467(7313): 285-290.[33] Gore A, Li Z, Fung HL,et al. Somatic coding mutations in human induced pluripotent stem cells. Nature. 2011; 471 (7336): 63-67.[34] Yu J, Vodyanik MA, Thomson JA, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007; 318(5858):1917-1920. [35] Woltjen K, Michael IP, Mohseni P, et al. PiggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature. 2009; 458(7239): 766-770.[36] Zhou W, Freed CR. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells. 2009; 27(11): 2667-2674.[37] Mack AA, Kroboth S, Rajesh D,et al. Generation of induced pluripotent stem cells from CD34+ cells across blood drawn from multiple donors with non-integrating episomal vectors. PLoS One. 2011; 6(11):e27956. [38] Si-Tayeb K, Noto FK, Duncan SA, et al. Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors. BMC Dev. Biol. 2010; 10:81.[39] Somers A, Jean JC, Sommer CA, et al. Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells. 2010; 28(10): 1728-1740.[40] Warren L, Manos PD, Ahfeldt T, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell. 2010; 7(5): 618-630. [41] Geertrui T, Katharina W, Joseph D, et al. Activation of pluripotency-associated genES in mouse embryonic fibroblasts bynon-viral transfection with in vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and c-Myc. Biomaterials. 2012; 33 (2): 412-417.[42] Kim D, Kim CH, Kim KS, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell. 2009; 4(6): 472-476.[43] Maekawa M, Yamaguchi K, Yamanaka S, et al. Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1. Nature. 2011; 474(7350): 225-229.[44] Moon JH, Heo JS, You S, et al. Two-step generation of induced pluripotent stem cells from mouse fibroblasts using Id3 and Oct4. J Mol Cell Biol. 2012; 4(1): 59-62.[45] Lyssiotis CA, Foreman RK, Staerk J, et al. Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of klf4. Proc Natl Acad Sci USA. 2009; 106(22): 8912-8917.[46] Kim JB, Zaehres H, Scholer HR, et al. Generation of induced pluripotent stem cells from neural stem cells. Nat Protoc. 2009; 4(10): 1464-1470.[47] Dani C, Chambers I, Smith A, et al. Paracrine induction of stem cell renewal by LIF-deficient cells: a new ES cell regulatory pathway. Dev Biol, 1998, 203(1): 149-162.[48] Ying QL, Nichols I, Chambers I, et al. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renew in collaboration with Stats. Cell. 2003; 115(3): 281-292[49] Qi X, Li TG, Zhao GQ, et al. BMP4 supports self-renewal of embryonic stem cells by inhibiting mitogen-activated protein kinase pathways. Proc Natl Acad Sci USA. 2004; 101(16): 6027-6032.[50] Paling NR, Wheadon H, Welham MJ, et al. Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent signaling. J Biol Chem. 2004; 279(46): 48063-48070.[51] Kunath T, Meloche S, Smith A, et al. FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development. 2007; 134(16): 2895-2902. [52] Zhang Z, Gao Y, Wu WS, et al. Efficient Generation of Fully Reprogrammed Human iPS Cells via Polycistronic Retroviral Vector and a New Cocktail of Chemical Compounds. PloS One. 2011; 6(10): e26592.[53] Shimada H, Hashimoto Y, Nakada A, et al. Accelerated generation of human induced pluripotent stem cells with retroviral transduction and chemical inhibitors under physiological hypoxia. Biochem Biophys Res Commun. 2012; 417(2): 659-664.[54] Zhang B, Pan X, Anderson TA, et al. microRNAs as oncogenes and tumor suppressors. Dev Biol. 2007; 302(1): 1-12.[55] Ying SY, Lin SL. Current perspectives in intronic micro RNAs (MiRNAs). J Biomed Sci. 2006; 13(1): 5-15.[56] Calin GA, Sevignani C, Croce CM, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA. 2004; 101(9) 2999-3004.[57] Lin SL, Chang DC, Ying SY, et al. Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA. 2008;14 (10) 2115-2124.[58] Yang CS, Li Z, Rana TM, et al. microRNAs modulate iPS cell generation. RNA. 2011; 17(8): 1451-1460.[59] Li Z, Yang CS, Rana TM, et al. Small RNA-mediated regulation of iPS cell generation. EMBO J. 2011; 30(5): 823-834.[60] Liao B, Esteban MA, Pei D, et al. MicroRNA Cluster 302-367 Enhances Somatic Cell Reprogramming by Accelerating a Mesenchymal-to-Epithelial Transition. J Biol Chem. 2011; 286(19): 17359-17364.[61] Judson RL, Babiarz JE, Venere M, et al. Embryonic stem cell specific microRNAs promote induced pluripotency. Nat Biotechnol. 2009; 27(5): 459-461. [62] Choi YJ, Lin CP, He L, et al. miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat Cell Biol. 2011; 13(11): 1153-1160.[63] Subramanyam D, Lamouille S, Blelloch R, et al. Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat Biotechnol. 2011; 29(5): 443-448. [64] Miyoshi N, Ishii H, Mori M, et al. Reprogramming of Mouse and Human Cells to Pluripotency Using Mature MicroRNAs. Cell Stem Cell. 2011; 8(6): 633-638.[65] Gardlik R. Inducing pluripotency using in vivo gene therapy. Med Hypotheses. 2012; 79(2): 197-201. [66] Zhou Q, Brown J, Melton DA, et al. In vivo reprogramming of adult pancreatic exocrine cells to β-cells. Nature. 2008; 455 (7213): 627-632.[67] Islas JF, Liu Y, Schwartz RJ, et al. Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors. Proc Natl Acad Sci USA. 2012; 109(32): 13016-13021. |